KWF
Implementation of Biomarkers 2027
Pre-proposal deadline: 20 October 2026 at 12:00 noon. Full proposal deadline: 23 February 2027 at 12:00 noon.
Last verified:
Details
| Funder | KWF |
| Budget | €1M–€4M |
| Deadline | 20 October 2026 |
| Duration | 3-5 years |
| Consortium | Required — minimum 4 participating parties (may include private partners) |
| Application | 2-stage: pre-proposal (opens 25 Aug 2026, closes 20 Oct 2026) → full proposal (opens 15 Dec 2026, closes 23 Feb 2027) → interviews May 2027 → funding decision June 2027 |
| TRL | 7-9 |
| Frequency | Annual |
| Eligible countries | NL |
Eligibility & scope
Open to multidisciplinary consortia (min. 4 parties) implementing clinical-grade oncology biomarkers into nationwide Dutch routine care at TRL 7–9. Requires HTA expertise in team, patient perspective integration, steering committee, and a project manager. Public-private collaborations encouraged with co-funding. PhD candidates strongly discouraged. Proposals must be submitted in English via KWF GMS.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Proof Of Concept 2026-2
Deadline: 2 Jun 2026KWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATKWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATINTER-LOCAL: International Call for Better Local Treatment of Rare and/or Hard to Treat Cancers
Deadline: 18 Jun 2026INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies
Deadline: 18 Jun 2026Up to €3M
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free